Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Kuang

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Bone Marrow Transplantation|October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remissionFeng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Bone Marrow Transplantation|October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remissionFeng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Pageof 30